Johan M. Spoor, CEO of Perspective Therapeutics ($CATX), made two open market purchases of company shares in the last year, totaling about $60,000. His most recent buy occurred on March 28, 2025. These purchases rank 2,826th among 4,983 individual insiders in our database, where the average buy amounts to roughly $1.5 million across 3.29 transactions. Spoor reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | Chief Executive Officer | A | Stock option (right to buy) | 735000 | $0.00 | 735,000.0000 | 74,337,990 | 9999.99% | 0.99% |
| March 28, 2025 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | Chief Executive Officer | P | Common Stock | 4650 | $2.21 | 87,683.0000 | 74,051,841 | 5.60% | 0.01% |
| March 28, 2025 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | Chief Executive Officer | P | Common Stock | 22026 | $2.24 | 87,683.0000 | 74,051,841 | 33.55% | 0.03% |
| March 3, 2025 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | Chief Executive Officer | A | Stock option (right to buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | P | Common Stock | 8000 | $3.77 | 55,257.0000 | 0 | 16.93% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | P | Common Stock | 5400 | $3.80 | 234,072.0000 | 0 | 2.36% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | P | Common Stock | 6600 | $3.80 | 234,072.0000 | 0 | 2.90% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | P | Common Stock | 14500 | $3.78 | 234,072.0000 | 0 | 6.60% | 0.00% |
| June 20, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | A | Stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Perspective Therapeutics, Inc. | $CATX | Spoor Johan M. | CEO | P | Common Stock | 100000 | $1.17 | 207,572.0000 | 0 | 92.96% | 0.00% |